Weighing the benefits of hepatocellular carcinoma surveillance against potential harms - PubMed (original) (raw)

COVID-19 and liver cancer: lost patients and larger tumours.

Geh D, Watson R, Sen G, French JJ, Hammond J, Turner P, Hoare T, Anderson K, McNeil M, McPherson S, Masson S, Dyson J, Donnelly M, MacDougal L, Patel P, Hudson M, Anstee QM, White S, Robinson S, Pandanaboyana S, Walker L, McCain M, Bury Y, Raman S, Burt A, Parkinson D, Haugk B, Darne A, Wadd N, Asghar S, Mariappan L, Margetts J, Stenberg B, Scott J, Littler P, Manas DM, Reeves HL. Geh D, et al. BMJ Open Gastroenterol. 2022 Apr;9(1):e000794. doi: 10.1136/bmjgast-2021-000794. BMJ Open Gastroenterol. 2022. PMID: 35450934 Free PMC article. Review.